GLP-1 use among young children with obesity in US remains rare but is rising rapidly
GLP-1 treatment late in life extends lifespan in animal model
GLP-1 weight-loss medication could slow aging and extend lifespan
Can GLP-1 drugs slow ageing? Mouse study shows promise
GLP-1 meds prompt rethink of obesity and eating disorder care
GLP-1 meds prompt rethink of obesity and eating disorder care
Researchers examine unanticipated benefits of GLP-1 medications - EurekAlert!
Do GLP-1 drugs like Ozempic prevent cancer? (Headlines suggest popular diabetes and weight-loss drugs prevent cancer, but epidemiologists warn that early observational data may be misleading.)
GLP-1 drugs linked to lower fracture risk in adults with type 2 diabetes - EurekAlert!
Marshall University researcher helps develop first international guidance on GLP-1 medications and women's reproductive health - EurekAlert!
Oral GLP-1 drugs may quiet the brain’s food craving circuit
GLP-1 diabetes drugs linked to increased risk of hair loss - EurekAlert!
Study finds no statistical link between use of semaglutide and other GLP-1 drugs and risk of degenerative eye disease in adults with type 2 diabetes - EurekAlert!
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment - EurekAlert!
Researchers find small increased risk of sudden vision loss associated with GLP-1 medications - EurekAlert!
GLP-1 agonists may help people with diabetes and long COVID - EurekAlert!
Online prescribing of GLP-1 receptor agonists - EurekAlert!
7 things to know about Medicare’s new GLP-1 coverage - EurekAlert!
A type of fibre that stimulates GLP-1 release approved for use in food
GLP-1 semaglutide induced 1.7x greater weight loss than diet alone despite identical caloric intake
